{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T08:28:45Z","timestamp":1714724925688},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Natural Science Foundation of Fujian, China","award":["2015J01467"],"award-info":[{"award-number":["2015J01467"]}]},{"name":"Key Clinical Specialty Discipline Construction Program of Fujian"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12035-016-9739-z","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T05:59:13Z","timestamp":1454651953000},"page":"1456-1466","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons"],"prefix":"10.1007","volume":"54","author":[{"given":"Hua-Pin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Gen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hui","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"issue":"4","key":"9739_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1474-4422(09)70023-7","volume":"8","author":"SC Johnston","year":"2009","unstructured":"Johnston SC, Mendis S, Mathers CD (2009) Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 8(4):345\u2013354. doi: 10.1016\/S1474-4422(09)70023-7","journal-title":"Lancet Neurol"},{"issue":"12","key":"9739_CR2","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1161\/STROKEAHA.111.635755","volume":"42","author":"L Liu","year":"2011","unstructured":"Liu L, Wang D, Wong KS, Wang Y (2011) Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke; a J Cereb Circ 42(12):3651\u20133654. doi: 10.1161\/STROKEAHA.111.635755","journal-title":"Stroke; a J Cereb Circ"},{"issue":"2","key":"9739_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.STR.25.2.333","volume":"25","author":"J Burn","year":"1994","unstructured":"Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C (1994) Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke; a J Cereb Circ 25(2):333\u2013337","journal-title":"Stroke; a J Cereb Circ"},{"issue":"7329","key":"9739_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists C","year":"2002","unstructured":"Antithrombotic Trialists C (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71\u201386","journal-title":"BMJ"},{"issue":"2","key":"9739_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P et al (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke; a J Cereb Circ 37(2):577\u2013617. doi: 10.1161\/01.STR.0000199147.30016.74","journal-title":"Stroke; a J Cereb Circ"},{"issue":"5","key":"9739_CR6","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1161\/STROKEAHA.107.497271","volume":"39","author":"MJ O\u2019Donnell","year":"2008","unstructured":"O\u2019Donnell MJ, Hankey GJ, Eikelboom JW (2008) Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review. Stroke; a J Cereb Circ 39(5):1638\u20131646. doi: 10.1161\/STROKEAHA.107.497271","journal-title":"Stroke; a J Cereb Circ"},{"key":"9739_CR7","doi-asserted-by":"crossref","unstructured":"Xie W, Zheng F, Zhong B, Song X (2015) Long-term antiplatelet mono- and dual therapies after ischemic stroke or transient ischemic attack: network meta-analysis. J Am Heart Assoc 4 (8). doi:10.1161\/jaha.115.002259","DOI":"10.1161\/JAHA.115.002259"},{"key":"9739_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12487","author":"DD Thompson","year":"2015","unstructured":"Thompson DD, Murray GD, Candelise L, Chen Z, Sandercock PA, Whiteley WN (2015) Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials. Int J Stroke Off J Int Stroke Soc. doi: 10.1111\/ijs.12487","journal-title":"Int J Stroke Off J Int Stroke Soc"},{"issue":"5","key":"9739_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.002","volume":"24","author":"L Tan","year":"2015","unstructured":"Tan L, Margaret B, Zhang JH, Hu R, Yin Y, Cao L, Feng H, Zhang Y (2015) Efficacy and safety of cilostazol therapy in ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(5):930\u2013938. doi: 10.1016\/j.jstrokecerebrovasdis.2014.12.002","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"9739_CR10","doi-asserted-by":"crossref","unstructured":"Qian Y, Bi Q (2015) Systematic study of cilostazol on secondary stroke prevention: a meta-analysis. Eur J Med Res 18 (1)","DOI":"10.1186\/s40001-015-0125-5"},{"issue":"3","key":"9739_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/ijs.12431","volume":"10","author":"X Pan","year":"2015","unstructured":"Pan X, Zhu Y, Zheng D, Liu Y, Yu F, Yang J (2015) Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials. Int J Stroke Off J Int Stroke Soc 10(3):317\u2013323. doi: 10.1111\/ijs.12431","journal-title":"Int J Stroke Off J Int Stroke Soc"},{"issue":"4","key":"9739_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ijs.12419","volume":"10","author":"MF Bakheet","year":"2015","unstructured":"Bakheet MF, Pearce LA, Hart RG (2015) Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials. Int J Stroke Off J Int Stroke Soc 10(4):501\u2013505. doi: 10.1111\/ijs.12419","journal-title":"Int J Stroke Off J Int Stroke Soc"},{"issue":"5644","key":"9739_CR13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.1.5644.614","volume":"1","author":"J Acheson","year":"1969","unstructured":"Acheson J, Danta G, Hutchinson EC (1969) Controlled trial of dipyridamole in cerebral vascular disease. Br Med J 1(5644):614\u2013615","journal-title":"Br Med J"},{"issue":"3","key":"9739_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.STR.8.3.301","volume":"8","author":"WS Fields","year":"1977","unstructured":"Fields WS, Lemak NA, Frankowski RF, Hardy RJ (1977) Controlled trial of aspirin in cerebral ischemia. Stroke; a J Cereb Circ 8(3):301\u2013314","journal-title":"Stroke; a J Cereb Circ"},{"key":"9739_CR15","doi-asserted-by":"crossref","unstructured":"Canadian (1978) A randomized trial of aspirin and sulfinpyrazone in threatened stroke. The Canadian Cooperative Study Group. NEngl J Med 299 (2):53\u201359. doi:10.1056\/NEJM197807132990201","DOI":"10.1056\/NEJM197807132990201"},{"issue":"21","key":"9739_CR16","first-page":"795","volume":"122","author":"R Reuther","year":"1980","unstructured":"Reuther R, Dorndorf W, Loew D (1980) The treatment of transitory ischemic attacks with acetylsalicylic acid: results of a double-blind-study (author\u2019s transl). MMW, Munch Med Wochenschr 122(21):795\u2013798","journal-title":"MMW, Munch Med Wochenschr"},{"issue":"5","key":"9739_CR17","first-page":"367","volume":"138","author":"B Guiraud-Chaumeil","year":"1982","unstructured":"Guiraud-Chaumeil B, Rascol A, David J, Boneu B, Clanet M, Bierme R (1982) Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial. Rev Neurol 138(5):367\u2013385","journal-title":"Rev Neurol"},{"issue":"1","key":"9739_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","volume":"14","author":"MG Bousser","year":"1983","unstructured":"Bousser MG, Eschwege E, Haguenau M (1983) \u2018AICLA\u2019 controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke; a J Cereb Circ 14(1):5\u201314","journal-title":"Stroke; a J Cereb Circ"},{"issue":"1","key":"9739_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.STR.14.1.15","volume":"14","author":"PS Sorensen","year":"1983","unstructured":"Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA (1983) Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke; a J Cereb Circ 14(1):15\u201322","journal-title":"Stroke; a J Cereb Circ"},{"issue":"3","key":"9739_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","volume":"16","author":"The American-Canadian Co-Operative Study group","year":"1985","unstructured":"The American-Canadian Co-Operative Study group (1985) Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. Stroke; a J Cereb Circ 16(3):406\u2013415","journal-title":"Stroke; a J Cereb Circ"},{"key":"9739_CR21","unstructured":"Swedish (1987) High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. Stroke; a J Cereb Circ 18 (2):325\u2013334"},{"issue":"8649","key":"9739_CR22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","volume":"1","author":"M Gent","year":"1989","unstructured":"Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS et al (1989) The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet (London, England) 1(8649):1215\u20131220","journal-title":"Lancet (London, England)"},{"issue":"8","key":"9739_CR23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.STR.21.8.1122","volume":"21","author":"European Stroke Prevention Study. ESPS Group","year":"1990","unstructured":"European Stroke Prevention Study. ESPS Group (1990) Stroke; a J Cereb Circ 21(8):1122\u20131130","journal-title":"Stroke; a J Cereb Circ"},{"issue":"12","key":"9739_CR24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","volume":"54","author":"B Farrell","year":"1991","unstructured":"Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54(12):1044\u20131054","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9038","key":"9739_CR25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CS Committee","year":"1996","unstructured":"CS Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (London, England) 348(9038):1329\u20131339","journal-title":"Lancet (London, England)"},{"issue":"1\u20132","key":"9739_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","volume":"143","author":"HC Diener","year":"1996","unstructured":"Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A (1996) European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143(1\u20132):1\u201313","journal-title":"J Neurol Sci"},{"issue":"9066","key":"9739_CR27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","volume":"349","author":"CAST (Chinese Acute Stroke Trial) Collaborative Group","year":"1997","unstructured":"CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet (London, England) 349(9066):1641\u20131649","journal-title":"Lancet (London, England)"},{"issue":"4","key":"9739_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/jscd.2000.7216","volume":"9","author":"F Gotoh","year":"2000","unstructured":"Gotoh F, Tohgi H, Hirai S, Terashi A, Fukuuchi Y, Otomo E, Shinohara Y, Itoh E et al (2000) Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 9(4):147\u2013157. doi: 10.1053\/jscd.2000.7216","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"issue":"22","key":"9739_CR29","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","volume":"289","author":"PB Gorelick","year":"2003","unstructured":"Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, Leurgans S (2003) Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 289(22):2947\u20132957. doi: 10.1001\/jama.289.22.2947","journal-title":"JAMA"},{"issue":"9","key":"9739_CR30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2169\/internalmedicine.42.793","volume":"42","author":"E Ito","year":"2003","unstructured":"Ito E, Takahashi A, Yamamoto H, Kuzuhara S, Uchiyama S, Nakajima M, Tokai Panaldine Aspirin Long-Term S (2003) Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke. Int Med (Tokyo, Japan) 42(9):793\u2013799","journal-title":"Int Med (Tokyo, Japan)"},{"issue":"4","key":"9739_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.str.0000063141.24491.50","volume":"34","author":"J Matias-Guiu","year":"2003","unstructured":"Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jimenez MD, Lago A, Melo T (2003) Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Stroke; a J Cereb Circ 34(4):840\u2013848. doi: 10.1161\/01.str.0000063141.24491.50","journal-title":"Stroke; a J Cereb Circ"},{"issue":"7","key":"9739_CR32","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000113757.34662.AA","volume":"62","author":"A Culebras","year":"2004","unstructured":"Culebras A, Rotta-Escalante R, Vila J, Dom\u00ednguez R, Abiusi G, Famulari A, Rey R, Bauso-Tosselli L et al (2004) Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology 62(7):1073\u20131080","journal-title":"Neurology"},{"issue":"9431","key":"9739_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J et al (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet (London, England) 364(9431):331\u2013337. doi: 10.1016\/S0140-6736(04)16721-4","journal-title":"Lancet (London, England)"},{"issue":"9523","key":"9739_CR34","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","volume":"367","author":"ES Group","year":"2006","unstructured":"Group ES, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (London, England) 367(9523):1665\u20131673. doi: 10.1016\/S0140-6736(06)68734-5","journal-title":"Lancet (London, England)"},{"issue":"11","key":"9739_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, Investigators F (2007) Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 6(11):961\u2013969. doi: 10.1016\/S1474-4422(07)70250-8","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"9739_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000111498","volume":"25","author":"Y Fukuuchi","year":"2008","unstructured":"Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, Hirano M, Shinohara Y et al (2008) A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. Cerebrovasc Dis (Basel, Switzerland) 25(1\u20132):40\u201349. doi: 10.1159\/000111498","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"6","key":"9739_CR37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1474-4422(08)70094-2","volume":"7","author":"Y Huang","year":"2008","unstructured":"Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W et al (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 7(6):494\u2013499. doi: 10.1016\/S1474-4422(08)70094-2","journal-title":"Lancet Neurol"},{"issue":"12","key":"9739_CR38","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","volume":"359","author":"RL Sacco","year":"2008","unstructured":"Sacco RL, Diener HC, Yusuf S, Cotton D, \u00d4unpuu S, Lawton WA, Palesch Y, Martin RH et al (2008) Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359(12):1238\u20131251","journal-title":"N Engl J Med"},{"issue":"6","key":"9739_CR39","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/strokeaha.107.505131","volume":"39","author":"Y Shinohara","year":"2008","unstructured":"Shinohara Y, Nishimaru K, Sawada T, Terashi A, Handa S, Hirai S, Hayashi K, Tohgi H et al (2008) Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): a randomized, double-blind, aspirin-controlled trial. Stroke; a J Cereb Circ 39(6):1827\u20131833. doi: 10.1161\/strokeaha.107.505131","journal-title":"Stroke; a J Cereb Circ"},{"issue":"6","key":"9739_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s12264-009-6192-2","volume":"25","author":"JJ Guo","year":"2009","unstructured":"Guo JJ, Xu E, Lin QY, Zeng GL, Xie HF (2009) Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke. Neurosci Bull 25(6):383\u2013390. doi: 10.1007\/s12264-009-6192-2","journal-title":"Neurosci Bull"},{"issue":"6","key":"9739_CR41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00415-009-5035-4","volume":"256","author":"S Uchiyama","year":"2009","unstructured":"Uchiyama S, Fukuuchi Y, Yamaguchi T (2009) The safety and efficacy of clopidogrel versus ticlopidine in Japanese stroke patients: combined results of two phase III, multicenter, randomized clinical trials. J Neurol 256(6):888\u2013897. doi: 10.1007\/s00415-009-5035-4","journal-title":"J Neurol"},{"issue":"4","key":"9739_CR42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/STROKEAHA.109.564906","volume":"41","author":"PMW Bath","year":"2010","unstructured":"Bath PMW, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C et al (2010) Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke; a J Cereb Circ 41(4):732\u2013738","journal-title":"Stroke; a J Cereb Circ"},{"issue":"10","key":"9739_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1474-4422(10)70198-8","volume":"9","author":"Y Shinohara","year":"2010","unstructured":"Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N et al (2010) Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 9(10):959\u2013968. doi: 10.1016\/S1474-4422(10)70198-8","journal-title":"Lancet Neurol"},{"issue":"9782","key":"9739_CR44","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0140-6736(11)60600-4","volume":"377","author":"MG Bousser","year":"2011","unstructured":"Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP et al (2011) Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (London, England) 377(9782):2013\u20132022. doi: 10.1016\/S0140-6736(11)60600-4","journal-title":"Lancet (London, England)"},{"issue":"1","key":"9739_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1747-4949.2010.00535.x","volume":"6","author":"GJ Hankey","year":"2011","unstructured":"Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, Mak KH, Bhatt DL et al (2011) Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke Off J Int Stroke Soc 6(1):3\u20139. doi: 10.1111\/j.1747-4949.2010.00535.x","journal-title":"Int J Stroke Off J Int Stroke Soc"},{"issue":"10","key":"9739_CR46","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/STROKEAHA.110.609370","volume":"42","author":"SU Kwon","year":"2011","unstructured":"Kwon SU, Hong KS, Kang DW, Park JM, Lee JH, Cho YJ, Yu KH, Koo JS et al (2011) Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke; a J Cereb Circ 42(10):2883\u20132890. doi: 10.1161\/STROKEAHA.110.609370","journal-title":"Stroke; a J Cereb Circ"},{"issue":"1","key":"9739_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000327036","volume":"32","author":"YS Lee","year":"2011","unstructured":"Lee YS, Bae HJ, Kang DW, Lee SH, Yu K, Park JM, Cho YJ, Hong KS et al (2011) Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis (Basel, Switzerland) 32(1):65\u201371. doi: 10.1159\/000327036","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"6","key":"9739_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1159\/000327035","volume":"31","author":"S Uchiyama","year":"2011","unstructured":"Uchiyama S, Ikeda Y, Urano Y, Horie Y, Yamaguchi T (2011) The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial. Cerebrovasc Dis (Basel, Switzerland) 31(6):601\u2013613. doi: 10.1159\/000327035","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"9","key":"9739_CR49","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJMoa1204133","volume":"367","author":"OR Benavente","year":"2012","unstructured":"Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA (2012) Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 367(9):817\u2013825. doi: 10.1056\/NEJMoa1204133","journal-title":"N Engl J Med"},{"issue":"1","key":"9739_CR50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H et al (2013) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369(1):11\u201319","journal-title":"N Engl J Med"},{"issue":"7A","key":"9739_CR51","first-page":"1144","volume":"35","author":"Y Kimura","year":"1985","unstructured":"Kimura Y, Tani T, Kanbe T, Watanabe K (1985) Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35(7A):1144\u20131149","journal-title":"Arzneimittelforschung"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9739-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9739-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T08:45:01Z","timestamp":1567586701000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9739"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9739-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}